Cyclic adenosine monophosphate (cAMP) response element‐binding protein (CREB) is
overexpressed and has an oncogenic role in hepatocellular carcinoma (HCC). Interleukin …

Aim To investigate the clinical significance of cyclic adenosine monophosphate-responsive
element-binding (CREB) and phosphorylated CREB (pCREB) expression in human …

Interleukin enhancer binding factor 2 (ILF2), a transcription factor, regulates cell growth by
inhibiting the stabilization of mRNA. Currently, its role has gained recognition as a factor in …

Abstract Interferon regulatory factor 1 (IRF-1) is a tumor suppressor gene in cancer biology
with anti-proliferative and pro-apoptotic effect on cancer cells, however mechanisms of IRF-1 …

CAMP responsive element binding protein 5 (CREB5) has been reported to be
overexpressed in several types of human cancers and has crucial roles in regulating cell …

Background CRBP-1, a cytosolic chaperone of vitamin A, is identified in a serious number of
cancers; however, its biological role in hepatocellular carcinoma (HCC) needs to be further …

Abstract CR6-interacting factor 1 (CRIF1) regulates cell cycle progression and the DNA
damage response. Here, we show that CRIF1 expression is decreased in hepatocellular …

ABSTRACT CR6-interacting factor 1 (Crif1) is a mitochondrial protein which is required for
the assembly of oxidative phosphorylation (OXPHOS) complexes. Our bioinformatics …

Aims Hepatocellular carcinoma (HCC) is a primary malignancy of the hepatocyte. Interleukin
enhancer binding factor 2 (ILF2) plays a role in the development of HCC. However, the …

Tumor microenvironment controls the selection of malignant cells capable of surviving in
stressful and hypoxic conditions. The transcription factor, cyclic AMP-responsive element …